Analyst
40cents
Equibles does not estimate personal net worth.
Mihul Panjwani is recorded as Analyst at 40cents. Mihul Panjwani has spoken on 1 earnings call across 1 company, most recently for Laurus Labs Limited on April 30, 2026. The companies whose calls Mihul Panjwani spoke on are classified in the Healthcare sector.
“My first question is about CDMO pipeline. Out of the expanding CDMO pipeline, how much is expected to convert into commercial revenues in FY27? And what is the revenue visibility from late-stage molecules?”
40cents
Analyst
Transcript header (unverified)
Laurus Labs Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call
Laurus Labs Limited
